Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether chenodeoxycholic acid decreases de novo
hepatic lipogenesis, hepatic fat content, hepatic triglyceride production and plasma
triglyceride concentrations and improves hepatic glucose metabolism in patients with the
metabolic syndrome, Familial Hypertriglyceridemia and Familial Combined Hyperlipidemia.